Technical Analysis for CTLT - Catalent, Inc.

Grade Last Price % Change Price Change
grade A 45.37 -0.20% -0.09
CTLT closed down 0.2 percent on Friday, May 17, 2019, on 87 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical CTLT trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Bollinger Band Squeeze Range Contraction -0.20%
Up 3 Days in a Row Strength -0.20%
Crossed Above 20 DMA Bullish 1.54%
Bollinger Band Squeeze Range Contraction 1.54%

Older signals for CTLT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment provides advanced oral delivery technologies, including formulation, development, and manufacturing of oral dose forms for prescription and consumer health products. This segment's oral dose forms include softgel, modified release technologies, and immediate release solid oral products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also offers analytical chemical and cell-based testing and scientific services, stability testing, respiratory products formulation and manufacturing, regulatory consulting, and bioanalytical testing for biologic products. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.
Biotechnology Biopharmaceutical Manufacturing Life Sciences Pharmaceutical Industry Pharmacy Pharmacology Dosage Forms Biologic Products Specialty Drugs In The United States Consumer Health Products Inventory Management Services
Is CTLT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 9 Catalent Pharma Solutions, Inc. -- Moody's downgrades Catalent's senior secured rating to Ba3, affirms B1 CFR rating; the outlook remains stable
May 8 Edited Transcript of CTLT earnings conference call or presentation 7-May-19 12:15pm GMT
May 7 Catalent Inc (CTLT) Q3 2019 Earnings Call Transcript
May 7 Catalent (CTLT) Surpasses Q3 Earnings Estimates
May 7 Catalent: Fiscal 3Q Earnings Snapshot
May 7 Catalent beats by $0.03, misses on revenue
May 7 Catalent, Inc. Reports Third Quarter Fiscal 2019 Results
May 6 Notable earnings before Tuesday’s open
Apr 30 Catalent (CTLT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Apr 24 Did Hedge Funds Drop The Ball On Catalent Inc (CTLT) ?
See more CTLT news...
Indicators
Indicator Value
52 Week High 47.04
52 Week Low 29.23
Average Volume 799,722
200-Day Moving Average 40.2311
50-Day Moving Average 42.7048
20-Day Moving Average 44.796
10-Day Moving Average 44.904
Average True Range 1.2684
ADX 26.8
+DI 29.2663
-DI 16.8449
Chandelier Exit (Long, 3 ATRs ) 43.2348
Chandelier Exit (Short, 3 ATRs ) 44.9552
Upper Bollinger Band 46.171
Lower Bollinger Band 43.421
Percent B (%b) 0.71
BandWidth 6.138941
MACD Line 0.6684
MACD Signal Line 0.769
MACD Histogram -0.1006
Fundamentals Value
Market Cap 5.68 Billion
Num Shares 125 Million
EPS 0.87
Price-to-Earnings (P/E) Ratio 52.15
Price-to-Sales 2.57
Price-to-Book 7.36
PEG Ratio 3.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 46.74
Resistance 3 (R3) 46.87 46.55 46.51
Resistance 2 (R2) 46.55 46.20 46.48 46.43
Resistance 1 (R1) 45.96 45.99 46.26 45.83 46.36
Pivot Point 45.64 45.64 45.79 45.57 45.64
Support 1 (S1) 45.05 45.29 45.35 44.92 44.38
Support 2 (S2) 44.73 45.08 44.66 44.31
Support 3 (S3) 44.14 44.73 44.23
Support 4 (S4) 44.01